John P. Schmid is CFO at Trius Therapeutics Inc (TSRX). They have made 8 open-market trades across 4 companies since 2011, most recently 2026-08-10.
CIK 0001478916
7 open-market purchases totalling $313K since 2023, against 1 sale. Across 6 scored buys the stock is up 27.0% at ninety days, and 19.5 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 57% | 71% | 83% |
| Avg Move | +5.2% | +12.6% | +27.0% |
| Alpha | +3.8% | +11.4% | +19.5% |
| Scored | 7 | 7 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BLSM | BUY | 2026-08-10 | 2026-08-10 | $16.00 | $96K | -4.5% | +33.7% | — |
| ANAB | SELL | 2026-03-30 | 2026-04-01 | $56.11 | $1.2M | +25.0% | +18.8% | +20.0% |
| XERS | BUY | 2024-08-12 | 2024-08-13 | $2.25 | $10K | +13.4% | +12.6% | +29.1% |
| XERS | BUY | 2024-08-09 | 2024-08-12 | $2.37 | $10K | +22.8% | +25.4% | +43.9% |
| XERS | BUY | 2024-05-10 | 2024-05-10 | $1.91 | $10K | +11.0% | +28.2% | +23.2% |
| DSGN | BUY | 2024-03-22 | 2024-03-25 | $3.72 | $166K | -3.8% | -6.6% | -14.1% |
| XERS | BUY | 2024-03-14 | 2024-03-14 | $2.16 | $10K | -4.2% | -13.6% | +4.7% |
| XERS | BUY | 2023-11-16 | 2023-11-17 | $1.51 | $10K | +1.6% | +8.2% | +75.4% |
| TSRX | SELL · 10b5-1 | 2012-06-22 | 2012-06-25 | $6.00 | $11K | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2012-03-01 | 2012-03-02 | $5.04 | $3K | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2012-02-02 | 2012-02-06 | $5.63 | $3K | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2012-01-03 | 2012-01-04 | $7.28 | $5K | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2011-12-01 | 2011-12-02 | $7.50 | $5K | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2011-11-07 | 2011-11-08 | $7.00 | $700 | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2011-11-01 | 2011-11-01 | $6.75 | $4K | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2011-10-26 | 2011-10-27 | $7.00 | $1K | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2011-10-03 | 2011-10-04 | $6.33 | $4K | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2011-09-01 | 2011-09-02 | $6.60 | $4K | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2011-08-01 | 2011-08-02 | $8.85 | $11K | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2011-07-20 | 2011-07-21 | $8.00 | $800 | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2011-07-01 | 2011-07-05 | $7.93 | $6K | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2011-06-01 | 2011-06-01 | $7.90 | $6K | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2011-05-16 | 2011-05-18 | $8.00 | $3K | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2011-05-05 | 2011-05-09 | $7.00 | $1K | N/A | N/A | N/A |
| TSRX | SELL · 10b5-1 | 2011-05-02 | 2011-05-03 | $5.73 | $4K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| TSRX |
| 107,639 |
| — |
| BBOT | 30,000 | — |
| Total | $4.1M |
Shares reported on the most recent Form 4, priced at the 2026-08-10 close. 2 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.